| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/28/2001 | DE19960640A1 Neue Stromelysin Inhibitoren New stromelysin inhibitors |
| 06/28/2001 | DE19960204A1 Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Norlbornylamino substituted derivatives, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 06/28/2001 | CA2717246A1 Use of quinoline and quinolizinone derivatives as chemotherapeutic agents |
| 06/28/2001 | CA2399584A1 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | CA2395520A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 06/28/2001 | CA2395471A1 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives |
| 06/28/2001 | CA2395435A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | CA2395300A1 Novel compounds |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395202A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | CA2395200A1 Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease |
| 06/28/2001 | CA2395108A1 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394864A1 Novel compounds |
| 06/28/2001 | CA2394834A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394604A1 Substituted acylhydroxamic acids and method of reducing tnf.alpha. levels |
| 06/28/2001 | CA2394603A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | CA2393367A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2393363A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | CA2393359A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2392127A1 Tryptase inhibitors |
| 06/28/2001 | CA2392121A1 Tryptase inhibitors |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2384326A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/27/2001 | EP1110957A1 Benzazole derivatives and their use as JNK modulators |
| 06/27/2001 | EP1110556A1 Preventives/remedies for multiple organ failure |
| 06/27/2001 | EP1110545A2 Pharmaceutical preparations for the targeted treatment of Morbus Crohn and Colitis Ulcerosa |
| 06/27/2001 | EP1109924A2 Methylation of plasmid vectors |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109901A2 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF |
| 06/27/2001 | EP1109828A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants |
| 06/27/2001 | EP1109813A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 06/27/2001 | EP1109809A1 Pyrroloquinolines for treatment of obesity |
| 06/27/2001 | EP1109804A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109803A1 Substituted imidazoles having cytokine inhibitory activity |
| 06/27/2001 | EP1109784A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands |
| 06/27/2001 | EP1109777A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/27/2001 | EP1109570A2 Method of modulating memory effector t-cells and compositions |
| 06/27/2001 | EP1109566A1 Gcp |
| 06/27/2001 | EP1109565A1 Gabab1aa receptor |
| 06/27/2001 | EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 06/27/2001 | EP1109534A1 Quick release pharmaceutical compositions of drug substances |
| 06/27/2001 | EP1109533A1 Pulmonary delivery of liposome-encapsulated cannabinoids |
| 06/27/2001 | EP1109532A1 Oral micro-emulsion composition of silybin |
| 06/27/2001 | EP1109453A1 Compositions and methods for treatment of mitochondrial diseases |
| 06/27/2001 | EP0734261B1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301264A Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists |
| 06/27/2001 | CN1301160A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal frailty |
| 06/27/2001 | CN1301147A Pharmaceutical compositions capable of being gelled |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1300625A Gelatin pill for woman and its preparing process |
| 06/27/2001 | CN1300621A Process for preparing snuff to treat cirrhosis ascites |
| 06/27/2001 | CN1300620A Process for preparing snuff to treat hepatitis B |
| 06/27/2001 | CN1300619A Process for preparing snuff to treat hepatitis A |
| 06/27/2001 | CN1300617A Composite Chinese medicine for regulating functions of human body |
| 06/27/2001 | CN1300615A Antalgesic plaster for liver and spleen |
| 06/27/2001 | CN1300613A Process for preparing 'Weilinsan' |
| 06/27/2001 | CN1300612A Medicine for treating gastrosis and its preparing process |
| 06/27/2001 | CN1300611A Medicine for treating hepatism and its preparing process |
| 06/27/2001 | CN1300608A Medicine-egg mixture for treating hepatitis B |
| 06/27/2001 | CN1300602A Chinese medicine for reducing cholesterol, biliary calcules and bile viscosity |
| 06/27/2001 | CN1300601A Recovery capsule for hepatitis and its preparing process |
| 06/27/2001 | CN1300600A Songzhi pill |
| 06/27/2001 | CN1067683C Substituted morpholine derivatives and their use as therapeutic agents |
| 06/27/2001 | CN1067584C Quick action powder for stomachache |
| 06/27/2001 | CN1067583C Chinese medicine for treating piles and its preparation |
| 06/27/2001 | CN1067582C Desensitizing chewing gum containing tea extract and is preparing process |
| 06/27/2001 | CN1067580C Medicinal composition for treating recurrent aphthae |
| 06/26/2001 | US6252070 Reacting aryl bromide with butyllithium and zinc bromide to give aryl zinc bromide; reacting with corresponding benzothiazine compound |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251940 Administering to the mammal suffering from a diseases responsive to inhibit monocyte and/or macrophase and/or lymphocyte activation and of lymphocyte proliferation an amide derivative |
| 06/26/2001 | US6251935 Administration of a racemic alpha-lipoic acid, enantiomers and pharmaceutically acceptable salts, amides, esters or thioester, in reduced or oxidized form as antimigraine agent |
| 06/26/2001 | US6251925 An agonists for human beta-3 adrenoceptor |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/26/2001 | US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 06/26/2001 | US6251909 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 06/26/2001 | US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/26/2001 | US6251884 Pharmacologically acceptable composition for inhibiting or treating liver disease or inflammatory condition of gastrointestinal tract in mammal, comprising sulfate of ursodeoxycholic acid or salt thereof, carrier |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 06/26/2001 | US6251419 Membrane system for controlled tissue regeneration in cases of diseases of the periodontium |
| 06/26/2001 | US6251371 Treatment of skin or mucosa inflammation by topical treatment with preparation containing dichlorobenzyl alcohol |
| 06/21/2001 | WO2001044489A2 Galactomannan oligosaccharides and methods for the production and use thereof |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044455A2 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 06/21/2001 | WO2001044294A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 06/21/2001 | WO2001044264A2 Novel stromelysin inhibitors |
| 06/21/2001 | WO2001044254A1 Cyclopenteneone derivatives |
| 06/21/2001 | WO2001044248A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | WO2001044245A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044241A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044231A1 Improved omeprazole process and compositions thereof |